Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

SHE:002275 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,176	2,192	2,168	1,954	1,739	1,564
Other Revenue	1.76	1.76	3.66	5.27	2.71	2.79
Revenue	2,178	2,194	2,172	1,960	1,741	1,566
Revenue Growth (YoY)	12.37%	1.03%	10.81%	12.55%	11.15%	-4.51%
Cost of Revenue	589.91	610.47	602.57	574.37	457.04	449.25
Gross Profit	1,588	1,584	1,569	1,385	1,284	1,117
Selling, General & Admin	882.04	888.26	920.66	812.68	722.13	628.74
Research & Development	178.55	173.29	158.06	217.04	201.6	147.56
Other Operating Expenses	41.46	32.28	29.89	36.09	32.8	30.4
Operating Expenses	1,111	1,103	1,109	1,070	957.81	803.92
Operating Income	476.79	480.47	460.41	315.65	326.37	313.31
Interest Expense	-15.33	-13.84	-16.36	-20.24	-18.21	-11.55
Interest & Investment Income	34.84	34.4	33.17	40.64	39.8	29.41
Currency Exchange Gain (Loss)	0.19	0.19	-0.08	-3.59	0.57	0.01
Other Non Operating Income (Expenses)	0.7	-0.25	0.05	-0.58	-1.23	-0.14
EBT Excluding Unusual Items	497.19	500.97	477.2	331.89	347.31	331.05
Gain (Loss) on Sale of Investments	5.1	4.65	1.19	0.16	1.77	-1.37
Gain (Loss) on Sale of Assets	78.81	83.36	1.67	31.26	15.5	-
Asset Writedown	2.16	-0.86	-0.17	-1.02	-8.12	-1.71
Other Unusual Items	63.24	55.82	38.39	83.89	72.61	16.2
Pretax Income	646.5	643.93	518.28	446.18	429.06	344.17
Income Tax Expense	120.16	122.4	96.99	116.65	85.34	67.14
Net Income	526.33	521.53	421.3	329.53	343.72	277.02
Net Income to Common	526.33	521.53	421.3	329.53	343.72	277.02
Net Income Growth	49.49%	23.79%	27.85%	-4.13%	24.08%	-29.36%
Shares Outstanding (Basic)	584	586	585	588	573	577
Shares Outstanding (Diluted)	584	586	585	588	573	577
Shares Change (YoY)	-0.32%	0.15%	-0.56%	2.72%	-0.74%	-1.39%
EPS (Basic)	0.90	0.89	0.72	0.56	0.60	0.48
EPS (Diluted)	0.90	0.89	0.72	0.56	0.60	0.48
EPS Growth	49.96%	23.61%	28.57%	-6.67%	25.00%	-28.36%
Free Cash Flow	519.57	506.16	472.85	466.4	266.15	392.52
Free Cash Flow Per Share	0.89	0.86	0.81	0.79	0.47	0.68
Dividend Per Share	0.600	0.600	0.600	0.800	0.900	0.400
Dividend Growth	-	-	-25.00%	-11.11%	125.00%	73.91%
Gross Margin	72.91%	72.17%	72.25%	70.69%	73.75%	71.32%
Operating Margin	21.89%	21.90%	21.20%	16.11%	18.74%	20.00%
Profit Margin	24.17%	23.77%	19.40%	16.81%	19.74%	17.68%
Free Cash Flow Margin	23.86%	23.07%	21.77%	23.80%	15.29%	25.06%
EBITDA	561.7	571.42	575.53	412.21	412.97	393.58
EBITDA Margin	25.79%	26.05%	26.50%	21.03%	23.72%	25.12%
D&A For EBITDA	84.91	90.95	115.12	96.55	86.6	80.27
EBIT	476.79	480.47	460.41	315.65	326.37	313.31
EBIT Margin	21.89%	21.90%	21.20%	16.11%	18.74%	20.00%
Effective Tax Rate	18.59%	19.01%	18.71%	26.15%	19.89%	19.51%
Revenue as Reported	2,178	2,194	2,172	1,960	1,741	1,566
Advertising Expenses	-	530.36	514.72	361.86	378.93	64.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.